Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 130   

Articles published

VRX 142.68 +0.21 (0.15%)
price chart
Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase ...
LAVAL, Quebec, Nov. 20, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that its Board of Directors has authorized a new securities repurchase program (the "Securities Repurchase Program").
Valeant Pharma says may buy back up to $2 billion worth of securities  Yahoo News UK
Ackman-Valeant Alliance Proved Unwieldy  Wall Street Journal
Related articles »  
Making Sense of the Valeant Pharmaceuticals International Inc. and Allergan ...
There's a lot of posturing and name-calling going on between Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) and Allergan, Inc. (NYSE:AGN).
Allergan Gets Into Trouble As Confidential Documents Are Unsealed  Bidness ETC
Most Critical Documents Supporting Allergan, Valeant  ValueWalk
Related articles »  
BRIEF-Nicox sells US ophthalmic diagnostics subsidiary to Valeant ...
Nov 17 (Reuters) - Nicox SA : * Announces acquisition of its U.S. ophthalmic diagnostics subsidiary, Nicox Inc., by Valeant Pharmaceuticals International, Inc. * Transaction worth up to $20 million, including $10 million upfront cash payment plus ...
Valeant Pharmaceuticals Completes Renovation Of US Headquarters In New ...
LAVAL, Quebec, Nov. 13, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S.
Valeant Disclosures Approved In Allergan Inside Trading Row  Law360 (subscription)
Physicians Continue to Voice Strong Support for Allergan via Open Letters to ...  Finances.com
Related articles »  
Valeant Comments On Allergan Announcement
17, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire ...
Bill Ackman Is A Winner: Valeant Pharmaceuticals Intl Inc. (VRX), Allergan Inc ...
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc. (NYSE:AGN) if it does not move with speed and increase its proposed $54 billion takeover bid.
Ackman's Pershing Square takes stake in drug maker Zoetis  The Globe and Mail
Valeant Could Win Even If It Loses Allergan: Real M&A  Bloomberg
Related articles »  
Stock Update: Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
Taking a look at the company's recent performance, Valeant Pharmaceuticals Intl Inc (VRX) reported third quarter earnings for fiscal 2014 on October 20th.
Valeant Pharmaceuticals Intl Sees Significant Drop in Short Interest (VRX)  Ticker Report
Short Interest in Valeant Pharmaceuticals Intl Declines By 17.0% (VRX)  sleekmoney
Related articles »  
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX), Motorola ...
Jeffrey Ubben's ValueAct Holdings, LP has released its quarterly 13F report. In this article, we will quickly review the fund's latest biggest holdings and a comparison on its previous holdings.
Valeant cuts stake in Allergan
Valeant Pharmaceuticals (NYSE:VRX) has slashed its stake in Allergan (NYSE:AGN) to 0.1% from 9.7%, three days after Actavis (NYSE:ACT) trumped its offer for the Botox maker.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Chimes in on Allergan ...
[PR Newswire] Valeant Pharmaceuticals Intl Inc (NYSE:VRX) today commented on the announcement that Allergan, Inc. (AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of ...